Molecular genetic characterization of the epstein–Barr Virus: a relationship with the clinical features of pediatric infectious mononucleosis

Introduction. Infectious mononucleosis (IM) is an high priority viral infection in children. Epstein-Barr virus (EBV) is the main etiological agent of IM. EBV is classified into two main types EBV-1 and EBV-2. In addition, different variants of the virus are isolated based on individual genes, among which the LMP-1 gene and the oncoprotein it encodes are the most well known. So far, the study of the clinical significance of EBV genetic diversity in EBV-IM in children in Russia has not been conducted. The aim of the study was to evaluate a relationship between EBV LMP-1 molecular genetic variants and clinical and laboratory manifestations of IM in children. Materials and methods. The material of the study was presented by blood leukocyte and saliva samples of children aged 117 years with EBV-IM (n = 69). A total of 132 EBV isolates were studied. For differential detection of EBV-1/EBV-2, we used a previously optimized one-round PCR variant with electrophoretic detection of amplification products in agarose gel. The nucleotide sequences of the C-terminal region of the LMP-1 gene were determined by Sanger sequencing followed by analysis of the obtained sequences using the MEGA X software. Multiple Factor Analysis was used to search for the relationship between LMP-1 variants and clinical and laboratory manifestations of IM (32 signs and 8 groups of signs). Results. It was established that only one type of virus, EBV-1, was identified in all children. At the same time, the severity of clinical manifestations of EBV-IM in children varied significantly (from 15.5 to 35.5 scores in total). Molecular genetic analysis of the sequences of the LMP-1 C-terminal region in Nizhny Novgorod region EBV isolates demonstrated a significant heterogeneity of the viral population, which was not limited only to their grouping according to known variants. According to the frequency of detection, B95-8 was the dominant variant of LMP-1 (60.66.0% of cases), other variants were less common (China 1, NC, Med and China 1+В95-8). It was found that EBV-IM proceeded more easily and with less severity of the intoxication syndrome in cases of infection with a virus having the molecular genetic profile of EBV-1/B95-8, in particular EBV-1/B95-8/E214D. Conversely, EBV-1/Med, as well as EBV-1/Med/L338S, EBV-1/Med/S229T, EBV-1/China 1/L338S and EBV-1/NC/S229T profiles were associated with more severe infection. Conclusion. For the first time, the influence of the genetic diversity of EBV on the clinical manifestations of IM in children was revealed. In the context of the tasks to be solved in this study, it is necessary to conduct a larger-scale and systemic studies in different territories of Russia.

[1]  Jiong Li,et al.  Risk of malignancy following exposure to Epstein-Barr Virus associated infectious mononucleosis: A nationwide population-based cohort study , 2022, Frontiers in Oncology.

[2]  P. Korać,et al.  Molecular Characterisation of Epstein–Barr Virus in Classical Hodgkin Lymphoma , 2022, International journal of molecular sciences.

[3]  T. Luedde,et al.  The Association between Infectious Mononucleosis and Cancer: A Cohort Study of 24,190 Outpatients in Germany , 2022, Cancers.

[4]  K. Smirnova,et al.  [Epstein-Barr virus (Herpesviridae: Gammaherpesvirinae: Lymphocryptovirus: Human gammaherpesvirus 4) in Kalmyks and Slavs living in Russia: virus types, LMP1 oncogene variants, and malignancies]. , 2022, Voprosy virusologii.

[5]  O. Utkin,et al.  Genetic diversity of the Epstein–Barr virus: a modern view of the problem , 2022, Journal of microbiology, epidemiology and immunobiology.

[6]  A. Tutelyan,et al.  Epidemiological characteristics of Epstein–Barr virus infection , 2022, Journal of microbiology, epidemiology and immunobiology.

[7]  Robert E. White,et al.  Do Epstein–Barr Virus Mutations and Natural Genome Sequence Variations Contribute to Disease? , 2021, Biomolecules.

[8]  Moriah L. Szpara,et al.  ICTV Virus Taxonomy Profile: Herpesviridae 2021 , 2021, The Journal of general virology.

[9]  Y. Gabbay,et al.  Genotypes of Epstein–Barr virus (EBV1/EBV2) in individuals with infectious mononucleosis in the metropolitan area of Belém, Brazil, between 2005 and 2016 , 2020, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

[10]  Д. С. Тихомиров,et al.  Клиническая значимость вирусологических методов верификации этиологии инфекционного мононуклеоза , 2020 .

[11]  А. В. Федорова,et al.  ВЭБ-мононуклеоз у детей в современных условиях , 2020 .

[12]  K. Smirnova,et al.  [Ancient variants of the Epstein-Barr virus (Herpesviridae, Lymphocryptovirus, HHV-4): hypotheses and facts.] , 2020, Voprosy virusologii.

[13]  Л. Н. Мазанкова,et al.  Клинические проявления инфекционного мононуклеоза при первичной или реактивированной герпесвирусной инфекции , 2020 .

[14]  Ольга Анатольевна Попова,et al.  Критерии оценки степени тяжести инфекционного мононуклеоза у детей , 2019 .

[15]  Gheyath K Nasrallah,et al.  Prevalence and molecular profiling of Epstein Barr virus (EBV) among healthy blood donors from different nationalities in Qatar , 2017, PloS one.

[16]  A. Dent,et al.  Epstein-Barr Virus Type 2 Infects T Cells in Healthy Kenyan Children , 2017, The Journal of infectious diseases.

[17]  M. V. Preciado,et al.  A novel recombinant variant of latent membrane protein 1 from Epstein Barr virus in Argentina denotes phylogeographical association , 2017, PloS one.

[18]  T. Jovanović,et al.  Analysis of the Variability of Epstein-Barr Virus Genes in Infectious Mononucleosis: Investigation of the Potential Correlation with Biochemical Parameters of Hepatic Involvement , 2016, Journal of medical biochemistry.

[19]  A. Chiang,et al.  Distribution, Persistence and Interchange of Epstein-Barr Virus Strains among PBMC, Plasma and Saliva of Primary Infection Subjects , 2015, PloS one.

[20]  Jérôme Pagès,et al.  Multiple factor analysis and clustering of a mixture of quantitative, categorical and frequency data , 2008, Comput. Stat. Data Anal..

[21]  O. Genoulaz,et al.  A prospective follow-up of Epstein-Barr virus LMP1 genotypes in saliva and blood during infectious mononucleosis. , 2005, The Journal of infectious diseases.

[22]  N. Raab-Traub,et al.  Signature amino acid changes in latent membrane protein 1 distinguish Epstein-Barr virus strains. , 1999, Virology.

[23]  E. Zabarovsky,et al.  Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP1) from a Chinese nasopharyngeal carcinoma. , 1991, The Journal of general virology.

[24]  E. Kieff,et al.  U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[25]  L. N. Mazankova,et al.  Infectious mononucleosis in children: clinical and laboratory characteristics depending on the disease etiology and phase of infection , 2020 .